$12.4B US molecular dx market
Molecular Diagnostics
Reach molecular lab directors, genomics leads, PCR technology buyers, and NGS platform decision-makers. Our molecular diagnostics segment covers hospital molecular labs, reference labs, and specialty genomics centers across the USA.
$12.4B
US Market Size
Molecular diagnostics 2024
11.2%
Market Growth
CAGR 2024–2030
4,200+
Molecular Labs
Dedicated molecular labs
42,000+
Verified Contacts
In this segment
Market Overview
US Molecular Dx Market Intelligence
Molecular diagnostics is the fastest-growing segment in clinical laboratory medicine, driven by PCR, NGS, and FISH technologies. The COVID-19 pandemic accelerated molecular testing infrastructure investment, and the market continues to expand into oncology, infectious disease, pharmacogenomics, and rare disease testing. NGS-based testing is projected to be the dominant growth driver through 2030.
Target molecular lab directors for PCR platform and reagent sales
Reach genomics leads at cancer centers for NGS instrument procurement
Connect with medical geneticists for rare disease testing solutions
Identify lab directors at reference labs for molecular test menu expansion
Database Coverage
42,000+
Verified contacts
3,800+
Companies profiled
Updated every 30 days
Key Roles Available
Molecular Lab Director
Genomics Lead
PCR Specialist
NGS Director
Medical Geneticist
Contact Breakdown by Role
Molecular Lab Director3,400+
Genomics / NGS Lead2,800+
PCR Specialist6,200+
Medical Geneticist1,900+
Bioinformatics Director1,400+
Top States by Contact Volume
1California
5,800+2Massachusetts
4,200+3New York
3,900+4Texas
3,100+5Maryland
2,400+Coverage across all 50 US states + 45 countries
Explore More Segments
Access verified contacts across all 8 specialized lab verticals.